Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Assessment of the modulation degrees of intensity-modulated radiation therapy plans.

Park SY, Kim JI, Chun M, Ahn H, Park JM.

Radiat Oncol. 2018 Dec 13;13(1):244. doi: 10.1186/s13014-018-1193-9.

2.

Correction to: Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21WAF1/CIP1 expression.

Ho DH, Kim H, Kim J, Sim H, Ahn H, Kim J, Seo H, Chung KC, Park BJ, Son I, Seol W.

Mol Brain. 2017 Oct 6;10(1):48. doi: 10.1186/s13041-017-0327-6. No abstract available.

3.

Concurrent progress of reprogramming and gene correction to overcome therapeutic limitation of mutant ALK2-iPSC.

Kim BY, Jeong S, Lee SY, Lee SM, Gweon EJ, Ahn H, Kim J, Chung SK.

Exp Mol Med. 2016 Jun 3;48(6):e237. doi: 10.1038/emm.2016.43.

4.

Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression.

Ho DH, Kim H, Kim J, Sim H, Ahn H, Kim J, Seo H, Chung KC, Park BJ, Son I, Seol W.

Mol Brain. 2015 Sep 18;8:54. doi: 10.1186/s13041-015-0145-7. Erratum in: Mol Brain. 2017 Oct 6;10(1):48.

Supplemental Content

Loading ...
Support Center